Literature DB >> 33173209

Serum MMP7 levels could guide metastatic therapy for prostate cancer.

Rebecca Tregunna1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33173209     DOI： 10.1038/s41585-020-00396-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy.

Authors:  T Szarvas; A Csizmarik; M Váradi; T Fazekas; A Hüttl; P Nyirády; B Hadaschik; V Grünwald; S Tschirdewahn; S F Shariat; S Sevcenco; A Maj-Hes; G Kramer
Journal:  Urol Oncol       Date:  2020-10-09       Impact factor: 3.498
  1 in total
  1 in total

1.  Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes.

Authors:  Xi Hong; Liang Mao; Luwei Xu; Qiang Hu; Ruipeng Jia
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.